Prevention of post-ERCP pancreatitis

Gastrointestinal Endoscopy

Volumn 51, Issue 1, 2000, Pages 100-103

  Haber, Gregory B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HIGH RISK PATIENT; HUMAN; MORTALITY; PANCREATITIS; PRIORITY JOURNAL; RISK ASSESSMENT; SKILL;

EID: 0033963082     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(00)70402-0     Document Type: Editorial

References (26)

1. A Andriulli L Gioacchino N Grazia A Mangia V Festa G Gambassi Medical treatment can prevent pancreatic injury after ERCP: a meta-analysis Gastrointest Endosc 51 2000 1 7
2. P Trap S Adamsen O Hart-Hansen M. Henriksen Severe and fatal complications after therapeutic ERCP: a prospective series of claims to insurance covering public hospitals Endoscopy 31 1999 125 130
3. ML Freeman DB Nelson S Sherman GB Haber M Herman P Dorsher Complications of endoscopic biliary sphincterotomy N Engl J Med 335 1996 909 918
4. S Loperfido G Angelini G Beneditti F Chilovi F Costan F De Berrardinis Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study Gastrointest Endosc 48 1998 1 10
5. S Sherman G Lehman ML Freeman D Earle J Watkins J Barnett Risk factors for post-ERCP pancreatitis: a prospective multicenter study [abstract] Am J Gastroenterol 92 1997 1639AB
6. ML Freeman DB Nelson JA Disario CS Overby RV Erickson ME Ryan Risk factors for post-ERCP pancreatitis: a prospective multicenter study [abstract] Gastrointest Endosc 49 1999 72AB
7. C Niederau R. Luthen Events inside the pancreatic acinar cell in acute pancreatitis: role of secretory blockade, calcium release and dehydration for the initiation of trypsinogen activation PG Lankisch EP DiMango Pancreatic disease 1999 Springer-Verlag Berlin/Heidelberg 14 23
8. AK Saluja ML. Steer Pathophysiology of pancreatitis: role of cytokines and other mediators of inflammation Digestion 60 Suppl 1999 27 33
9. J. Scholmerich Immunologic mechanisms in acute pancreatitis PG Lankisch EP DiMango Pancreatic disease 1999 Springer-Verlag Berlin/Heidelberg 24 35
10. AD McCutcheon D. Race Experimental pancreatitis: a possible etiology of post-operative pancreatitis Ann Surg 155 1962 523 531
11. KF Binmoeller R Dumas AG Harns JP. Delmont Effect of somatostatin analog oetreotide on human sphincter of Oddi Dig Dis Sci 37 1992 773 777
12. PC Hayes JM Davis JA Lewis IAD. Bouchier Meta-analysis of value of propanolol in prevention of variceal haemorrhage Lancet 336 1990 153 156
13. S Borzak RM. Ridker Discordance between meta-analyses and large-scale randomized, controlled trials Ann Intern Med 123 1995 873 877
14. SR Rosellini F. Miglio Beta-blockers and variceal haemorrhage Lancet 336 1990 1503 1504
15. G Cavallini A Tittobello L Frulloni E Masci A Mariani V DiFrancesco Gabexate for the prevention of pancreatic damage related to ERCP N Engl J Med 335 1996 919 923
16. E Esber S Sherman D Earle J Pezzi K Gottleib G. Lehman Complications of major papilla pancreatic sphincterotomy: a review of 236 patients [abstract] Gastrointest Endosc 43 1995 1405AB
17. P Tarnasky J Cunningham P Cotton B Hoffman Y Palesch J Freeman Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis Endoscopy 29 1997 252 257
18. S Sherman TA Ruffolo RH Hawes GA. Lehman Complications of endoscopic sphincterotomy: a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondialated ducts Gastroenterology 101 1991 1068 1075
19. G. Aliperti Complications related to diagnostic and therapeutic ERCP Gastrointest Endosc Clin N Am 6 1996 379 407
20. A Smithline W Silverman D Rogers R Nisi M Wiersma P Jamidar Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy induced pancreatitis in high risk patients Gastrointest Endosc 39 1993 652 657
21. PR Tarnasky YY Palesch JT Cunningham PD Mauldin PB Cotton RH. Hawes Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction Gastroenterology 115 1998 1518 1524
22. S Sherman D Earle L Bucksot P Baute K Gottleib G Lehman Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)–induced pancreatitis?: a final analysis of a randomized prospective study [abstract] Gastrointest Endosc 43 1996 AB413
23. AK Banerjee RJC. Steele Current views on the pathophysiology of acute biliary pancreatitis Gut 36 1995 803 805
24. SW Schmid W Uhl MW. Buchler Acute pancreatitis: bacterial translocation and pancreatic infections PG Lankisch EP DiMango Pancreatic disease 1999 Springer-Verlag Berlin/Heidelberg 39 54
25. AN Kingsnorth SW Galloway LJ. Formela Randomised double-blind phase II trial of lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis Br J Surg 82 1995 1414 1420
26. CJ McKay F Curran C Sharples JN Baxter CW. Imrie Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis Br J Surg 84 1997 1239 1243